Heyman Richard A.
Transaction: 07/24/2026
SELL
Change
-3,500
Price
$1.60
Filing
07/28/2026
Type
SELL
ORIC Pharmaceuticals, Inc.
ORIC • Biotechnology
$12.86
▲ +0.12 (+0.94%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.39B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 14.13Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$12.86
Change0.94%
Shares Out108.01M
Market Cap$1.39B
Enterprise Value$1.12B
52W Range7.23 - 14.93
Beta0.97
P/E-9.90
P/B3.64
P/FCF-12.39
EV/EBITDA-7.64
EV/FCF-10.03
Price$12.86
Change0.94%
Shares Out108.01M
Market Cap$1.39B
Enterprise Value$1.12B
52W Range7.23 - 14.93
Beta0.97
P/E-9.90
P/B3.64
P/FCF-12.39
EV/EBITDA-7.64
EV/FCF-10.03
Earnings Yield-10.10%
FCF Yield-8.07%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.03
Current Ratio14.13
Quick Ratio14.13
Target$21.00
Target Upside63.30%
Target Median$21.00
Target Range15.00 - 27.00
Volume1.15M
Avg Volume1.90M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
88/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 14.13Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
100/100
Bullish
Bullish
10
Hold
0
Bearish
0
Price Target
2026-08-13
Low
$15.00
Mean
$19.00
Median
$15.00
High
$27.00
Insider Transactions
Recent executive and insider activity
Heyman Richard A.
Transaction: 07/24/2026
SELL
Change
-7,000
Price
$12.02
Filing
07/28/2026
Type
SELL
Heyman Richard A.
Transaction: 07/06/2026
SELL
Change
-300
Price
$12.00
Filing
07/08/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Heyman Richard A. | SELL | -3,500 | $1.60 | 07/24/2026 | 07/28/2026 |
| Heyman Richard A. | SELL | -7,000 | $12.02 | 07/24/2026 | 07/28/2026 |
| Heyman Richard A. | SELL | -300 | $12.00 | 07/06/2026 | 07/08/2026 |
| Piscitelli Dominic | SELL | -52,000 | $13.51 | 02/24/2026 | 02/26/2026 |
| Piscitelli Dominic | SELL | -52,000 | $4.36 | 02/24/2026 | 02/26/2026 |
| Heyman Richard A. | SELL | -3,500 | $12.00 | 01/16/2026 | 01/20/2026 |
| Chacko Jacob | BUY | +112,500 | Not reported | 01/02/2026 | 01/06/2026 |
| Chacko Jacob | BUY | +675,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Multani Pratik S | BUY | +35,500 | Not reported | 01/02/2026 | 01/06/2026 |
| Multani Pratik S | BUY | +214,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Piscitelli Dominic | BUY | +34,500 | Not reported | 01/02/2026 | 01/06/2026 |
| Piscitelli Dominic | BUY | +206,500 | $8.17 | 01/02/2026 | 01/06/2026 |
| Dier Mardi | BUY | +40,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Heyman Richard A. | BUY | +40,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Hoerter Steven L. | BUY | +40,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Kunkel Lori Anne | BUY | +40,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| You Angie | BUY | +40,000 | $8.17 | 01/02/2026 | 01/06/2026 |
| Chacko Jacob | SELL | -33,374 | $9.06 | 12/16/2025 | 12/17/2025 |
| Piscitelli Dominic | SELL | -10,720 | $9.06 | 12/16/2025 | 12/17/2025 |
| Multani Pratik S | SELL | -10,720 | $9.06 | 12/16/2025 | 12/17/2025 |